BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36270793)

  • 21. Risk of Nursing Home Admission in Cerebral Small Vessel Disease.
    Bergkamp MI; Wissink JGJ; van Leijsen EMC; Ghafoorian M; Norris DG; van Dijk EJ; Platel B; Tuladhar AM; de Leeuw FE
    Stroke; 2018 Nov; 49(11):2659-2665. PubMed ID: 30355195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.
    van der Holst HM; van Uden IW; Tuladhar AM; de Laat KF; van Norden AG; Norris DG; van Dijk EJ; Esselink RA; Platel B; de Leeuw FE
    Neurology; 2015 Nov; 85(18):1569-77. PubMed ID: 26446068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-shell Diffusion MRI Models for White Matter Characterization in Cerebral Small Vessel Disease.
    Konieczny MJ; Dewenter A; Ter Telgte A; Gesierich B; Wiegertjes K; Finsterwalder S; Kopczak A; Hübner M; Malik R; Tuladhar AM; Marques JP; Norris DG; Koch A; Dietrich O; Ewers M; Schmidt R; de Leeuw FE; Duering M
    Neurology; 2021 Feb; 96(5):e698-e708. PubMed ID: 33199431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.
    van Leijsen EMC; van Uden IWM; Ghafoorian M; Bergkamp MI; Lohner V; Kooijmans ECM; van der Holst HM; Tuladhar AM; Norris DG; van Dijk EJ; Rutten-Jacobs LCA; Platel B; Klijn CJM; de Leeuw FE
    Neurology; 2017 Oct; 89(15):1569-1577. PubMed ID: 28878046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease.
    Zeestraten EA; Lawrence AJ; Lambert C; Benjamin P; Brookes RL; Mackinnon AD; Morris RG; Barrick TR; Markus HS
    Neurology; 2017 Oct; 89(18):1869-1876. PubMed ID: 28978655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral small vessel disease and stroke: Linked by stroke aetiology, but not stroke lesion location or size.
    Sperber C; Hakim A; Gallucci L; Arnold M; Umarova RM
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107589. PubMed ID: 38244646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease.
    Peters N; van Leijsen E; Tuladhar AM; Barro C; Konieczny MJ; Ewers M; Lyrer P; Engelter ST; Kuhle J; Duering M; de Leeuw FE
    J Stroke; 2020 Sep; 22(3):369-376. PubMed ID: 33053952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural network efficiency predicts conversion to dementia.
    Tuladhar AM; van Uden IW; Rutten-Jacobs LC; Lawrence A; van der Holst H; van Norden A; de Laat K; van Dijk E; Claassen JA; Kessels RP; Markus HS; Norris DG; de Leeuw FE
    Neurology; 2016 Mar; 86(12):1112-9. PubMed ID: 26888983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral small vessel disease burden and cognitive and functional outcomes after stroke: A multicenter prospective cohort study.
    Georgakis MK; Fang R; Düring M; Wollenweber FA; Bode FJ; Stösser S; Kindlein C; Hermann P; Liman TG; Nolte CH; Kerti L; Ikenberg B; Bernkopf K; Poppert H; Glanz W; Perosa V; Janowitz D; Wagner M; Neumann K; Speck O; Dobisch L; Düzel E; Gesierich B; Dewenter A; Spottke A; Waegemann K; Görtler M; Wunderlich S; Endres M; Zerr I; Petzold G; Dichgans M;
    Alzheimers Dement; 2023 Apr; 19(4):1152-1163. PubMed ID: 35876563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.
    Gyanwali B; Shaik MA; Tan BY; Venketasubramanian N; Chen C; Hilal S
    J Alzheimers Dis; 2019; 67(4):1209-1219. PubMed ID: 30714960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Small Vessel Disease Burden Is Associated With Accelerated Poststroke Cognitive Decline: A 1-Year Follow-Up Study.
    Liang Y; Chen YK; Liu YL; Mok VCT; Ungvari GS; Chu WCW; Seo SW; Tang WK
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):336-343. PubMed ID: 31480986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Longitudinal Course of Cognitive and Motor Symptoms in Patients With Cerebral Small Vessel Disease.
    Bergkamp MI; Jacob MA; Cai M; Claassen JA; Kessels RPC; Esselink R; Tuladhar AM; De Leeuw FE
    Neurology; 2024 Mar; 102(5):e209148. PubMed ID: 38382000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical Vascular Brain Lesions in Young Adults With Acute Ischemic Stroke.
    De Giuli V; Grassi M; Besana M; Zedde M; Zini A; Lodigiani C; Marcheselli S; Cavallini A; Micieli G; Rasura M; DeLodovici ML; Tomelleri G; Checcarelli N; Chiti A; Giorli E; Del Sette M; Tancredi L; Toriello A; Braga M; Morotti A; Pezzini D; Locatelli M; Mazzoleni V; Bonacina S; Gamba M; Magoni M; Patella R; Spalloni A; Maria Simone A; Pascarella R; Beretta S; Padovani A; Gasparotti R; Pezzini A;
    Stroke; 2022 Apr; 53(4):1190-1198. PubMed ID: 34727743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Dementia in Cerebral Small Vessel Disease Using an Automatic Diffusion Tensor Image Segmentation Technique.
    Williams OA; Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Mackinnon AD; Morris RG; Markus HS; Barrick TR; Charlton RA
    Stroke; 2019 Oct; 50(10):2775-2782. PubMed ID: 31510902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural network changes in cerebral small vessel disease.
    Tuladhar AM; Tay J; van Leijsen E; Lawrence AJ; van Uden IWM; Bergkamp M; van der Holst E; Kessels RPC; Norris D; Markus HS; De Leeuw FE
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):196-203. PubMed ID: 31744851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral Perfusion and the Burden of Small Vessel Disease in Patients Referred to a Memory Clinic.
    Onkenhout L; Appelmans N; Kappelle LJ; Koek D; Exalto L; de Bresser J; Biessels GJ;
    Cerebrovasc Dis; 2020; 49(5):481-486. PubMed ID: 33075786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting cerebral small vessel disease to promote healthy aging: Preserving physical and cognitive functions in the elderly.
    Chung CP; Ihara M; Hilal S; Chen LK
    Arch Gerontol Geriatr; 2023 Jul; 110():104982. PubMed ID: 36868073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.